Revalia Bio

West Haven, CT · Founded 2021 · Privately Held (backing)

Operator of a platform intended to redefine organ donation and reinvent drug development. Revalia Bio is based in West Haven, CT and was founded in 2021. It was valued at $35.3 million at its seed round in Oct 2024, the last priced event on record. It has raised $26.8 million across 1 recorded round; the latest was a $12.3 million early-stage round in Oct 2024.

PMV mark · valuation
$35.3M
Oct 2026
Priced at
its seed round
Oct 2024
Total raised
$26.8M
Last round
Early Stage VC
Oct 2024
What is Revalia Bio worth?
$35.3MPrivateMarketView mark · Oct 2026

Valued at $35.3M at its seed round, Oct 2024. Nothing has traded since.

Free account
More of Revalia Bio with a free account
  • ·The complete investor list: 11 names
  • ·Watch Revalia Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Revalia Bio funding history

1 rounds
DateRoundRaisedPost-money
Oct 2024Early Stage VC$12.3M▮
Unlock post-money valuations

Membership and data by Private Market View

Revalia Bio valuation

Revalia Bio was valued at $35.3 million at its seed round in Oct 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Revalia Bio raised?

Revalia Bio has raised $26.8 million in total; 1 of its rounds is on record. The largest on record was a $12.3 million early-stage round in Oct 2024.

Revalia Bio has filed 1 Form D with the SEC, most recently in Nov 2024 ($12.3 million sold to 32 investors).

How Revalia Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Revalia Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Revalia Bio

What is Revalia Bio worth?
Revalia Bio is valued at $35.3M as of Oct 2026. Valued at $35.3M at its seed round, Oct 2024. Nothing has traded since.
How much has Revalia Bio raised?
Revalia Bio has raised $26.8M in total funding across 1 recorded rounds.
When did Revalia Bio last raise?
Revalia Bio last raised in Oct 2024 (Early Stage VC), raising $12.3M.